Abstract
Background: Antimicrobial resistance (AMR) is an increasing challenge confronting healthcare professionals, posing a serious threat to global public health. Without effective antimicrobials, the success of major surgery can be compromised, undermining many advances in healthcare. A pilot study within our OMFS unit demonstrated perioperative use of various antimicrobials for varied lengths of time when surgically managing facial fractures. As per the World Health Organisation (WHO) global action plan on antimicrobial resistance, with our microbiology team we developed and implemented a shortened antimicrobial protocol for use in the surgical management of mid 1/3rd facial fractures.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
